FDA Inspection 1309034 — Keck Medical Center of USC (USC Kenneth Norris Cancer Hospital)
The FDA completed an inspection of Keck Medical Center of USC (USC Kenneth Norris Cancer Hospital) on March 11, 2026 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 11, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Los Angeles, CA (United States)